Skip to content

tDCS on Precuneus in MCS: Repeated Stimulations

Repeated Stimulation of the Precuneus in Chronic Patients in Minimally Conscious State: a Placebo-controlled Randomized Clinical Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02702362
Enrollment
33
Registered
2016-03-08
Start date
2014-12-31
Completion date
2015-08-31
Last updated
2016-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients in Minimally Conscious State After a Severe Brain Injury

Keywords

disorders of consciousness, minimally conscious state, traumatic brain injury, stroke, transcranial direct current stimulation

Brief summary

In this study researchers will apply transcranial direct current stimulation (tDCS) for 5 consecutive days in chronic patients in minimally conscious state (MCS).

Detailed description

Positive effects of tDCS in patients in MCS was showed in a recent study published in Neurology. But the effects went down after 1 or 2 hours. To increase the lasting of the effects, a new study will evaluate the effects of tDCS on the precuneus cortex for 5 consecutive days in chronic patients in MCS. 2 sessions of 5 days of stimulation will be realized, one session will be real (anodal stimulation) and one placebo (sham stimulation). After each stimulation, behavioral improvement will be assessed with the Coma Recovery Scale Revised (CRS-R). A final assessment will be done 5 days after the end of the sessions to assess the long term effect of the tDCS. Researchers expected to see an improvement of the CRS-R total score at the end of the anodal session and that this improvement persists for 5 days.

Interventions

DEVICEtranscranial direct current stimulation

anodal transcranial direct current stimulation on the precuneus cortex for the anodal session and sham stimulation (5secondes of tDCS) for the sham session.

Sponsors

Hangzhou Normal University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* post comatose patients * patients in minimally conscious state * patients with stable condition * patients free of sedative drugs and Na+ or Ca++ blockers (e.g., carbamazepine) or NMDA receptor antagonist (e.g., dextromethorphan)

Exclusion criteria

* premorbid neurology antecedent * patients in coma or vegetative state * patients \< 1 months after the acute brain injury * patients with a metallic cerebral implant or a pacemaker (in line with the safety criteria for tDCS in humans)

Design outcomes

Primary

MeasureTime frameDescription
Change in the CRS-R total scoreAfter each stimulation and 5 days later for anodal and sham sessions (total: 1 month)Improvement of the CRS-R total score after the end of the anodal session and 5 days later but no change for the sham session

Secondary

MeasureTime frameDescription
Influence of the time since insultone monthInfluence of the time since insult of the results. Researchers expected that the longer a patient is in MCS, the lower is his/her improvement after the tDCS session.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026